Zobrazeno 1 - 10
of 237
pro vyhledávání: '"Twito, T."'
Publikováno v:
Animal Genetics. Dec2011, Vol. 42 Issue 6, p642-649. 8p. 5 Charts.
Autor:
Breadner, Daniel1 (AUTHOR) daniel.breadner@lhsc.on.ca, Hwang, David M.2 (AUTHOR), Husereau, Don3 (AUTHOR), Cheema, Parneet4,5 (AUTHOR), Doucette, Sarah6 (AUTHOR), Ellis, Peter M.7,8 (AUTHOR) juergensr@hhsc.ca, Kassam, Shaqil9 (AUTHOR), Leighl, Natasha5,10 (AUTHOR), Maziak, Donna E.11 (AUTHOR), Selvarajah, Shamini12,13 (AUTHOR), Sheffield, Brandon S.14 (AUTHOR), Juergens, Rosalyn A.7,8 (AUTHOR)
Publikováno v:
Current Oncology. Oct2024, Vol. 31 Issue 10, p6017-6031. 15p.
Autor:
Grinberg, R., Roisman, L., Geva, S., Lefterova, M., Quinn, K., Soussan Gutman, L., Dvir, A., Yair, R., Twito, T., Lanman, R., Peled, N.
Publikováno v:
In Journal of Thoracic Oncology October 2018 13(10) Supplement:S925-S926
Autor:
Geva, S., Belilovski Rozenblum, A., Twito, T., Grinberg, R., Dvir, A., Soussan Gutman, L., Roisman, L., Ilouze, M., Dudnik, E., Zer, A., Rotem, O., Lanman, R., Peled, N.
Publikováno v:
In Journal of Thoracic Oncology October 2018 13(10) Supplement:S878-S878
Autor:
Grinberg, R., Roisman, L.C., Geva, S., Soussan-Gutman, L., Dvir, A., Yair, R., Twito, T., Larman, R., Peled, N.
Publikováno v:
In Journal of Thoracic Oncology April 2018 13(4) Supplement:S35-S36
Autor:
Geva, S., Rozenblum, A. Belilovski, Ilouze, M., Roisman, L., Dudnik, E., Zer, A., Twito, T., Dvir, A., Soussan-Gutman, L., Lanman, R., Peled, N.
Publikováno v:
In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2224-S2225
Autor:
Geva, S., Twito, T., Dvir, A., Soussan-Gutman, L., Ilouze, M., Roisman, L.C., Dudnik, E., Zer, A., Lanman, R.B., Peled, N.
Publikováno v:
In Annals of Oncology April 2017 28 Supplement 2:ii45-ii45
Publikováno v:
Animal Genetics; Feb2014, Vol. 45 Issue 1, p87-95, 9p
Autor:
Laufer-Geva S; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Rozenblum AB; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Twito T; Teva Pharmaceutical Industries, Ltd., West Chester, Pennsylvania., Grinberg R; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel., Dvir A; Teva Pharmaceutical Industries, Ltd., West Chester, Pennsylvania., Soussan-Gutman L; Teva Pharmaceutical Industries, Ltd., West Chester, Pennsylvania., Ilouze M; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Roisman LC; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel., Dudnik E; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Zer A; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Rotem O; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Lanman RB; Guardant Health, Inc., Redwood City, California., Peled N; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel. Electronic address: nirp@clalit.org.il.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2018 Nov; Vol. 13 (11), pp. 1705-1716. Date of Electronic Publication: 2018 Aug 16.
Autor:
Dudnik E; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA., Twito T; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA., Faull I; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA., Dvir A; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA., Soussan-Gutman L; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA., Purim O; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA., Lanman RB; Elizabeth Dudnik and Ofer Purim, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva; Tal Twito, Addie Dvir, and Lior Soussan-Gutman, TEVA Pharmaceuticals Industries, Shoam, Israel; and Iris Faull and Richard B. Lanman, Guardant Health, Redwood City, CA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2018 Nov; Vol. 2, pp. 1-6.